spacer
spacer

PDBsum entry 1jqh

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
1jqh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
291 a.a. *
Ligands
SO4 ×3
ANP ×3
Metals
_MG
Waters ×252
* Residue conservation analysis
PDB id:
1jqh
Name: Transferase
Title: Igf-1 receptor kinase domain
Structure: Igf-1 receptor kinase. Chain: a, b, c. Fragment: kinase domain. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
Biol. unit: Trimer (from PQS)
Resolution:
2.10Å     R-factor:   0.195     R-free:   0.219
Authors: A.Pautsch,A.Zoephel,H.Ahorn,W.Spevak,R.Hauptmann,H.Nar
Key ref:
A.Pautsch et al. (2001). Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure, 9, 955-965. PubMed id: 11591350 DOI: 10.1016/S0969-2126(01)00655-4
Date:
07-Aug-01     Release date:   19-Apr-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P08069  (IGF1R_HUMAN) -  Insulin-like growth factor 1 receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1367 a.a.
291 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.1  - receptor protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+
ADP
Bound ligand (Het Group name = ANP)
matches with 81.25% similarity
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/S0969-2126(01)00655-4 Structure 9:955-965 (2001)
PubMed id: 11591350  
 
 
Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation.
A.Pautsch, A.Zoephel, H.Ahorn, W.Spevak, R.Hauptmann, H.Nar.
 
  ABSTRACT  
 
BACKGROUND: The insulin-like growth-factor-1 (IGF-1) receptor, which is widely expressed in cells that have undergone oncogenic transformation, is emerging as a novel target in cancer therapy. IGF-1-induced receptor activation results in autophosphorylation of cytoplasmic kinase domains and enhances their capability to phosphorylate downstream substrates. Structures of the homologous insulin receptor kinase (IRK) exist in an open, unphosphorylated form and a closed, trisphosphorylated form. RESULTS: We have determined the 2.1 A crystal structure of the IGF-1 receptor protein tyrosine kinase domain phosphorylated at two tyrosine residues within the activation loop (IGF-1RK2P) and bound to an ATP analog. The ligand is not in a conformation compatible with phosphoryl transfer, and the activation loop is partially disordered. Compared to the homologous insulin receptor kinase, IGF-1RK2P is trapped in a half-closed, previously unobserved conformation. Observed domain movements can be dissected into two orthogonal rotational components. CONCLUSIONS: Conformational changes upon kinase activation are triggered by the degree of phosphorylation and are crucially dependent on the conformation of the proximal end of the kinase activation loop. This IGF-1RK structure will provide a molecular basis for the design of selective antioncogenic therapeutic agents.
 
  Selected figure(s)  
 
Figure 5.
Figure 5. Active Center and AMP-PNP Binding(a) AMP-PNP interactions in the active site of IGF-1RK2P. The protein is shown as a backbone representation (the glycine-rich loop is orange and transparent, the hinge region is magenta, the catalytic loop is green, and the activation loop is light yellow). Atoms are color coded by type: carbon is yellow, oxygen is red, nitrogen is blue, sulfur is green, phosphorous is purple, and Mg2+ is black. Water molecules are blue-green spheres.
 
  The above figure is reprinted by permission from Cell Press: Structure (2001, 9, 955-965) copyright 2001.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19647025 F.Brahimi, A.Malakhov, H.B.Lee, M.Pattarawarapan, L.Ivanisevic, K.Burgess, and H.U.Saragovi (2009).
A peptidomimetic of NT-3 acts as a TrkC antagonist.
  Peptides, 30, 1833-1839.  
19199650 M.L.Peach, N.Tan, S.J.Choyke, A.Giubellino, G.Athauda, T.R.Burke, M.C.Nicklaus, and D.P.Bottaro (2009).
Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening.
  J Med Chem, 52, 943-951.  
18385815 M.Muddassar, F.A.Pasha, H.W.Chung, K.H.Yoo, C.H.Oh, and S.J.Cho (2008).
Receptor guided 3D-QSAR: a useful approach for designing of IGF-1R inhibitors.
  J Biomed Biotechnol, 2008, 837653.  
18451558 Y.Mori, T.Hirokawa, K.Aoki, H.Satomi, S.Takeda, M.Aburada, and K.Miyamoto (2008).
Structure activity relationships of quinoxalin-2-one derivatives as platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors, derived from molecular modeling.
  Chem Pharm Bull (Tokyo), 56, 682-687.  
17318838 A.Garza-Garcia, D.S.Patel, D.Gems, and P.C.Driscoll (2007).
RILM: a web-based resource to aid comparative and functional analysis of the insulin and IGF-1 receptor family.
  Hum Mutat, 28, 660-668.  
17586502 B.P.Craddock, C.Cotter, and W.T.Miller (2007).
Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region.
  FEBS Lett, 581, 3235-3240.  
17325667 D.Mahadevan, L.Cooke, C.Riley, R.Swart, B.Simons, K.Della Croce, L.Wisner, M.Iorio, K.Shakalya, H.Garewal, R.Nagle, and D.Bearss (2007).
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
  Oncogene, 26, 3909-3919.  
17089440 R.D.Hubbard, and J.L.Wilsbacher (2007).
Advances towards the Development of ATP-Competitive Small-Molecule Inhibitors of the Insulin-Like Growth Factor Receptor (IGF-IR).
  ChemMedChem, 2, 41-46.  
17164530 S.W.Cowan-Jacob, G.Fendrich, A.Floersheimer, P.Furet, J.Liebetanz, G.Rummel, P.Rheinberger, M.Centeleghe, D.Fabbro, and P.W.Manley (2007).
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia.
  Acta Crystallogr D Biol Crystallogr, 63, 80-93.
PDB codes: 2hyy 2hz0 2hz4 2hzi 2hzn
16799620 K.Breuhahn, T.Longerich, and P.Schirmacher (2006).
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
  Oncogene, 25, 3787-3800.  
16793764 W.Li, and W.T.Miller (2006).
Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase.
  J Biol Chem, 281, 23785-23791.  
16055020 F.Hofmann, and C.García-Echeverría (2005).
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
  Drug Discov Today, 10, 1041-1047.  
15343278 N.J.Dibb, S.M.Dilworth, and C.D.Mol (2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
  Nat Rev Cancer, 4, 718-727.  
12707268 S.Li, N.D.Covino, E.G.Stein, J.H.Till, and S.R.Hubbard (2003).
Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor.
  J Biol Chem, 278, 26007-26014.
PDB code: 1p14
14501110 S.Munshi, D.L.Hall, M.Kornienko, P.L.Darke, and L.C.Kuo (2003).
Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution.
  Acta Crystallogr D Biol Crystallogr, 59, 1725-1730.
PDB code: 1p4o
12360255 P.De Meyts, and J.Whittaker (2002).
Structural biology of insulin and IGF1 receptors: implications for drug design.
  Nat Rev Drug Discov, 1, 769-783.  
12138114 S.Munshi, M.Kornienko, D.L.Hall, J.C.Reid, L.Waxman, S.M.Stirdivant, P.L.Darke, and L.C.Kuo (2002).
Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity.
  J Biol Chem, 277, 38797-38802.
PDB code: 1m7n
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer